BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Heng BC, Aubel D, Fussenegger M. An overview of the diverse roles of G-protein coupled receptors (GPCRs) in the pathophysiology of various human diseases. Biotechnology Advances 2013;31:1676-94. [DOI: 10.1016/j.biotechadv.2013.08.017] [Cited by in Crossref: 105] [Cited by in F6Publishing: 99] [Article Influence: 11.7] [Reference Citation Analysis]
Number Citing Articles
1 Wehr MC, Galinski S, Rossner MJ. Monitoring G protein-coupled receptor activation using the protein fragment complementation technique split TEV. Methods Mol Biol 2015;1272:107-18. [PMID: 25563180 DOI: 10.1007/978-1-4939-2336-6_8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
2 Meisenberg A, Kaschuba D, Balfanz S, Jordan N, Baumann A. Molecular and functional profiling of histamine receptor-mediated calcium ion signals in different cell lines. Anal Biochem 2015;486:96-101. [PMID: 26151682 DOI: 10.1016/j.ab.2015.06.037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
3 Santos GA, Duarte DA, Parreiras-E-Silva LT, Teixeira FR, Silva-Rocha R, Oliveira EB, Bouvier M, Costa-Neto CM. Comparative analyses of downstream signal transduction targets modulated after activation of the AT1 receptor by two β-arrestin-biased agonists. Front Pharmacol 2015;6:131. [PMID: 26191004 DOI: 10.3389/fphar.2015.00131] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
4 Bassani D, Pavan M, Federico S, Spalluto G, Sturlese M, Moro S. The Multifaceted Role of GPCRs in Amyotrophic Lateral Sclerosis: A New Therapeutic Perspective? Int J Mol Sci 2022;23:4504. [PMID: 35562894 DOI: 10.3390/ijms23094504] [Reference Citation Analysis]
5 Tripp RA, Mark Tompkins S. Antiviral effects of inhibiting host gene expression. Curr Top Microbiol Immunol 2015;386:459-77. [PMID: 25007848 DOI: 10.1007/82_2014_409] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
6 Li Z, Ji X, Wang W, Liu J, Liang X, Wu H, Liu J, Eggert US, Liu Q, Zhang X. Ammonia Induces Autophagy through Dopamine Receptor D3 and MTOR. PLoS One 2016;11:e0153526. [PMID: 27077655 DOI: 10.1371/journal.pone.0153526] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
7 Loth MK, Donaldson ZR. Oxytocin, Dopamine, and Opioid Interactions Underlying Pair Bonding: Highlighting a Potential Role for Microglia. Endocrinology 2021;162:bqaa223. [PMID: 33367612 DOI: 10.1210/endocr/bqaa223] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
8 Wu J, Yin Q, Zhang C, Geng J, Wu H, Hu H, Ke X, Zhang Y. Function Prediction for G Protein-Coupled Receptors through Text Mining and Induction Matrix Completion. ACS Omega 2019;4:3045-54. [PMID: 31459527 DOI: 10.1021/acsomega.8b02454] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Liu L, Fan Z, Rovira X, Xue L, Roux S, Brabet I, Xin M, Pin JP, Rondard P, Liu J. Allosteric ligands control the activation of a class C GPCR heterodimer by acting at the transmembrane interface. Elife 2021;10:e70188. [PMID: 34866572 DOI: 10.7554/eLife.70188] [Reference Citation Analysis]
10 Sharaf A, Mensching L, Keller C, Rading S, Scheffold M, Palkowitsch L, Djogo N, Rezgaoui M, Kestler HA, Moepps B, Failla AV, Karsak M. Systematic Affinity Purification Coupled to Mass Spectrometry Identified p62 as Part of the Cannabinoid Receptor CB2 Interactome. Front Mol Neurosci 2019;12:224. [PMID: 31616248 DOI: 10.3389/fnmol.2019.00224] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Heng BC, Zhang X, Aubel D, Bai Y, Li X, Wei Y, Fussenegger M, Deng X. An overview of signaling pathways regulating YAP/TAZ activity. Cell Mol Life Sci 2021;78:497-512. [DOI: 10.1007/s00018-020-03579-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
12 Martynowycz MW, Shiriaeva A, Ge X, Hattne J, Nannenga BL, Cherezov V, Gonen T. MicroED structure of the human adenosine receptor determined from a single nanocrystal in LCP. Proc Natl Acad Sci U S A 2021;118:e2106041118. [PMID: 34462357 DOI: 10.1073/pnas.2106041118] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
13 König C, Cárdenas MI, Giraldo J, Alquézar R, Vellido A. Label noise in subtype discrimination of class C G protein-coupled receptors: A systematic approach to the analysis of classification errors. BMC Bioinformatics 2015;16:314. [PMID: 26415951 DOI: 10.1186/s12859-015-0731-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
14 Almeida JG, Preto AJ, Koukos PI, Bonvin AM, Moreira IS. Membrane proteins structures: A review on computational modeling tools. Biochimica et Biophysica Acta (BBA) - Biomembranes 2017;1859:2021-39. [DOI: 10.1016/j.bbamem.2017.07.008] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 10.4] [Reference Citation Analysis]
15 Kleinau G, Müller A, Biebermann H. Oligomerization of GPCRs involved in endocrine regulation. J Mol Endocrinol 2016;57:R59-80. [PMID: 27151573 DOI: 10.1530/JME-16-0049] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 3.8] [Reference Citation Analysis]
16 Lütjens R, Rocher JP. Recent advances in drug discovery of GPCR allosteric modulators for neurodegenerative disorders. Curr Opin Pharmacol 2017;32:91-5. [PMID: 28135635 DOI: 10.1016/j.coph.2017.01.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
17 Alhosaini K, Azhar A, Alonazi A, Al-Zoghaibi F. GPCRs: The most promiscuous druggable receptor of the mankind. Saudi Pharm J 2021;29:539-51. [PMID: 34194261 DOI: 10.1016/j.jsps.2021.04.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Kumari P, Ghosh E, Shukla AK. Emerging Approaches to GPCR Ligand Screening for Drug Discovery. Trends in Molecular Medicine 2015;21:687-701. [DOI: 10.1016/j.molmed.2015.09.002] [Cited by in Crossref: 61] [Cited by in F6Publishing: 54] [Article Influence: 8.7] [Reference Citation Analysis]
19 Navarrete LC, Barrera NP, Huidobro-Toro JP. Vas deferens neuro-effector junction: from kymographic tracings to structural biology principles. Auton Neurosci 2014;185:8-28. [PMID: 24956963 DOI: 10.1016/j.autneu.2014.05.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
20 Lim FPL, Dolzhenko AV. 1,3,5-Triazine-based analogues of purine: From isosteres to privileged scaffolds in medicinal chemistry. European Journal of Medicinal Chemistry 2014;85:371-90. [DOI: 10.1016/j.ejmech.2014.07.112] [Cited by in Crossref: 55] [Cited by in F6Publishing: 32] [Article Influence: 6.9] [Reference Citation Analysis]
21 Yuan S, Hu Z, Filipek S, Vogel H. W246 6.48 Opens a Gate for a Continuous Intrinsic Water Pathway during Activation of the Adenosine A 2A Receptor. Angew Chem 2015;127:566-9. [DOI: 10.1002/ange.201409679] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
22 Shaik FA, Singh N, Arakawa M, Duan K, Bhullar RP, Chelikani P. Bitter taste receptors: Extraoral roles in pathophysiology. Int J Biochem Cell Biol 2016;77:197-204. [PMID: 27032752 DOI: 10.1016/j.biocel.2016.03.011] [Cited by in Crossref: 63] [Cited by in F6Publishing: 54] [Article Influence: 10.5] [Reference Citation Analysis]
23 Wang X, Pang G. Amplification systems of weak interaction biosensors: applications and prospects. Sensor Review 2015;35:30-42. [DOI: 10.1108/sr-03-2014-629] [Cited by in Crossref: 6] [Article Influence: 0.9] [Reference Citation Analysis]
24 Krishna Deepak RNV, Verma RK, Hartono YD, Yew WS, Fan H. Recent Advances in Structure, Function, and Pharmacology of Class A Lipid GPCRs: Opportunities and Challenges for Drug Discovery. Pharmaceuticals (Basel) 2021;15:12. [PMID: 35056070 DOI: 10.3390/ph15010012] [Reference Citation Analysis]
25 Stauch B, Cherezov V. Serial Femtosecond Crystallography of G Protein-Coupled Receptors. Annu Rev Biophys 2018;47:377-97. [PMID: 29543504 DOI: 10.1146/annurev-biophys-070317-033239] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
26 Akhmedov D, Kirkby NS, Mitchell JA, Berdeaux R. Imaging of Tissue-Specific and Temporal Activation of GPCR Signaling Using DREADD Knock-In Mice. Methods Mol Biol 2019;1947:361-76. [PMID: 30969428 DOI: 10.1007/978-1-4939-9121-1_21] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Veya L, Piguet J, Vogel H. Single Molecule Imaging Deciphers the Relation between Mobility and Signaling of a Prototypical G Protein-coupled Receptor in Living Cells. J Biol Chem 2015;290:27723-35. [PMID: 26363070 DOI: 10.1074/jbc.M115.666677] [Cited by in Crossref: 25] [Cited by in F6Publishing: 9] [Article Influence: 3.6] [Reference Citation Analysis]
28 Yuan S, Hu Z, Filipek S, Vogel H. W246(6.48) opens a gate for a continuous intrinsic water pathway during activation of the adenosine A2A receptor. Angew Chem Int Ed Engl 2015;54:556-9. [PMID: 25403323 DOI: 10.1002/anie.201409679] [Cited by in Crossref: 16] [Cited by in F6Publishing: 34] [Article Influence: 2.0] [Reference Citation Analysis]
29 Wang D. The essential role of G protein-coupled receptor (GPCR) signaling in regulating T cell immunity. Immunopharmacol Immunotoxicol 2018;40:187-92. [PMID: 29433403 DOI: 10.1080/08923973.2018.1434792] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
30 Jafurulla M, Nalli A, Chattopadhyay A. Membrane cholesterol oxidation in live cells enhances the function of serotonin 1A receptors. Chemistry and Physics of Lipids 2017;203:71-7. [DOI: 10.1016/j.chemphyslip.2017.01.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
31 Ahn SH, Park SY, Baek JE, Lee SY, Baek WY, Lee SY, Lee YS, Yoo HJ, Kim H, Lee SH, Im DS, Lee SK, Kim BJ, Koh JM. Free Fatty Acid Receptor 4 (GPR120) Stimulates Bone Formation and Suppresses Bone Resorption in the Presence of Elevated n-3 Fatty Acid Levels. Endocrinology 2016;157:2621-35. [PMID: 27145004 DOI: 10.1210/en.2015-1855] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
32 Scott BM, Chen SK, Bhattacharyya N, Moalim AY, Plotnikov SV, Heon E, Peisajovich SG, Chang BSW. Coupling of Human Rhodopsin to a Yeast Signaling Pathway Enables Characterization of Mutations Associated with Retinal Disease. Genetics 2019;211:597-615. [PMID: 30514708 DOI: 10.1534/genetics.118.301733] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
33 Murtaza B, Asghar F, Patoli D. GPR75: An exciting new target in metabolic syndrome and related disorders. Biochimie 2022. [DOI: 10.1016/j.biochi.2022.01.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Sarkar P, Chattopadhyay A. Insights into cellular signaling from membrane dynamics. Arch Biochem Biophys 2021;701:108794. [PMID: 33571482 DOI: 10.1016/j.abb.2021.108794] [Reference Citation Analysis]
35 Doijen J, Van Loy T, Landuyt B, Luyten W, Schols D, Schoofs L. Advantages and shortcomings of cell-based electrical impedance measurements as a GPCR drug discovery tool. Biosens Bioelectron. 2019;137:33-44. [PMID: 31077988 DOI: 10.1016/j.bios.2019.04.041] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
36 Omble A, Kulkarni K. GPCRs that Rhoar the Guanine nucleotide exchange factors. Small GTPases 2021;:1-16. [PMID: 33849392 DOI: 10.1080/21541248.2021.1896963] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Hounsou C, Baehr C, Gasparik V, Alili D, Belhocine A, Rodriguez T, Dupuis E, Roux T, Mann A, Heissler D, Pin JP, Durroux T, Bonnet D, Hibert M. From the Promiscuous Asenapine to Potent Fluorescent Ligands Acting at a Series of Aminergic G-Protein-Coupled Receptors. J Med Chem 2018;61:174-88. [PMID: 29219316 DOI: 10.1021/acs.jmedchem.7b01220] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
38 Hutchings CJ. A review of antibody-based therapeutics targeting G protein-coupled receptors: an update. Expert Opin Biol Ther 2020;20:925-35. [PMID: 32264722 DOI: 10.1080/14712598.2020.1745770] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
39 Galinski S, Wichert SP, Rossner MJ, Wehr MC. Multiplexed profiling of GPCR activities by combining split TEV assays and EXT-based barcoded readouts. Sci Rep 2018;8:8137. [PMID: 29802268 DOI: 10.1038/s41598-018-26401-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
40 Hutchings CJ. Mini-review: antibody therapeutics targeting G protein-coupled receptors and ion channels. Antib Ther 2020;3:257-64. [PMID: 33912796 DOI: 10.1093/abt/tbaa023] [Reference Citation Analysis]
41 Wang HX, Chen YH, Zhou JX, Hu XY, Tan C, Yan Y, Huang QL, Shen JY, Xu HC, Li F, Gong ZY, Xu T, Chen JX. Overexpression of G-protein-coupled receptors 65 in glioblastoma predicts poor patient prognosis. Clin Neurol Neurosurg 2018;164:132-7. [PMID: 29223793 DOI: 10.1016/j.clineuro.2017.11.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
42 Mordalski S, Wojtuch A, Podolak I, Kurczab R, Bojarski AJ. 2D SIFt: a matrix of ligand-receptor interactions. J Cheminform 2021;13:66. [PMID: 34496955 DOI: 10.1186/s13321-021-00545-9] [Reference Citation Analysis]
43 Misawa K, Mima M, Imai A, Mochizuki D, Misawa Y, Endo S, Ishikawa R, Kanazawa T, Mineta H. The neuropeptide genes SST, TAC1, HCRT, NPY, and GAL are powerful epigenetic biomarkers in head and neck cancer: a site-specific analysis. Clin Epigenetics 2018;10:52. [PMID: 29682090 DOI: 10.1186/s13148-018-0485-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
44 Azam S, Haque ME, Jakaria M, Jo SH, Kim IS, Choi DK. G-Protein-Coupled Receptors in CNS: A Potential Therapeutic Target for Intervention in Neurodegenerative Disorders and Associated Cognitive Deficits. Cells 2020;9:E506. [PMID: 32102186 DOI: 10.3390/cells9020506] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
45 Liu H, Wang W, Xu Z, Liu C, He D, Du L, Li M, Yu X, Sun J. FFA4 receptor (GPR120): A hot target for the development of anti-diabetic therapies. European Journal of Pharmacology 2015;763:160-8. [DOI: 10.1016/j.ejphar.2015.06.028] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
46 Correll CC, McKittrick BA. Biased ligand modulation of seven transmembrane receptors (7TMRs): functional implications for drug discovery. J Med Chem 2014;57:6887-96. [PMID: 24697360 DOI: 10.1021/jm401677g] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
47 Sonoda K. Molecular biology of gynecological cancer. Oncol Lett 2016;11:16-22. [PMID: 26834851 DOI: 10.3892/ol.2015.3862] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
48 Coudrat T, Christopoulos A, Sexton PM, Wootten D. Structural features embedded in G protein-coupled receptor co-crystal structures are key to their success in virtual screening. PLoS One 2017;12:e0174719. [PMID: 28380046 DOI: 10.1371/journal.pone.0174719] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
49 Abdul Sani NF, Amir Hamzah AIZ, Abu Bakar ZH, Mohd Yusof YA, Makpol S, Wan Ngah WZ, Damanhuri HA. Gene Expression Profile in Different Age Groups and Its Association with Cognitive Function in Healthy Malay Adults in Malaysia. Cells 2021;10:1611. [PMID: 34199148 DOI: 10.3390/cells10071611] [Reference Citation Analysis]
50 Gendaszewska-Darmach E, Drzazga A, Koziołkiewicz M. Targeting GPCRs Activated by Fatty Acid-Derived Lipids in Type 2 Diabetes. Trends Mol Med 2019;25:915-29. [PMID: 31377146 DOI: 10.1016/j.molmed.2019.07.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
51 Galland L. The gut microbiome and the brain. J Med Food. 2014;17:1261-1272. [PMID: 25402818 DOI: 10.1089/jmf.2014.7000] [Cited by in Crossref: 248] [Cited by in F6Publishing: 213] [Article Influence: 35.4] [Reference Citation Analysis]
52 Coudrat T, Simms J, Christopoulos A, Wootten D, Sexton PM. Improving virtual screening of G protein-coupled receptors via ligand-directed modeling. PLoS Comput Biol 2017;13:e1005819. [PMID: 29131821 DOI: 10.1371/journal.pcbi.1005819] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
53 Wintgens JP, Rossner MJ, Wehr MC. Characterizing Dynamic Protein-Protein Interactions Using the Genetically Encoded Split Biosensor Assay Technique Split TEV. Methods Mol Biol 2017;1596:219-38. [PMID: 28293890 DOI: 10.1007/978-1-4939-6940-1_14] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
54 Reinecke BA, Wang H, Zhang Y. Recent Advances in the Drug Discovery and Development of Dualsteric/ Bitopic Activators of G Protein-Coupled Receptors. Curr Top Med Chem 2019;19:2378-92. [PMID: 31833462 DOI: 10.2174/1568026619666191009164609] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
55 Dobrin A, Saxena P, Fussenegger M. Synthetic biology: applying biological circuits beyond novel therapies. Integrative Biology 2016;8:409-30. [DOI: 10.1039/c5ib00263j] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
56 Lu J, Fang B, Zheng Y, Yu X, Huang G, Wang Z, Deng X, Guan S. 1,3-dichloro-2-propanol induced lipid accumulation in HepG2 cells through cAMP/protein kinase A and AMP-activated protein kinase pathways via Gi/o-coupled receptors. Environ Toxicol Pharmacol 2017;55:118-26. [PMID: 28843851 DOI: 10.1016/j.etap.2017.07.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
57 Kaur H, Carvalho J, Looso M, Singh P, Chennupati R, Preussner J, Günther S, Albarrán-Juárez J, Tischner D, Classen S, Offermanns S, Wettschureck N. Single-cell profiling reveals heterogeneity and functional patterning of GPCR expression in the vascular system. Nat Commun 2017;8:15700. [PMID: 28621310 DOI: 10.1038/ncomms15700] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 9.4] [Reference Citation Analysis]
58 Wauson EM, Dbouk HA, Ghosh AB, Cobb MH. G protein-coupled receptors and the regulation of autophagy. Trends Endocrinol Metab 2014;25:274-82. [PMID: 24751357 DOI: 10.1016/j.tem.2014.03.006] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 5.1] [Reference Citation Analysis]
59 Wehr MC, Rossner MJ. Split protein biosensor assays in molecular pharmacological studies. Drug Discov Today 2016;21:415-29. [PMID: 26610415 DOI: 10.1016/j.drudis.2015.11.004] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 5.7] [Reference Citation Analysis]
60 Akhmedov D, Mendoza-Rodriguez MG, Rajendran K, Rossi M, Wess J, Berdeaux R. Gs-DREADD Knock-In Mice for Tissue-Specific, Temporal Stimulation of Cyclic AMP Signaling. Mol Cell Biol 2017;37:e00584-16. [PMID: 28167604 DOI: 10.1128/MCB.00584-16] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
61 Ceredig RA, Massotte D. Fluorescent knock-in mice to decipher the physiopathological role of G protein-coupled receptors. Front Pharmacol 2014;5:289. [PMID: 25610398 DOI: 10.3389/fphar.2014.00289] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
62 Zhou C, Dai X, Chen Y, Shen Y, Lei S, Xiao T, Bartfai T, Ding J, Wang MW. G protein-coupled receptor GPR160 is associated with apoptosis and cell cycle arrest of prostate cancer cells. Oncotarget 2016;7:12823-39. [PMID: 26871479 DOI: 10.18632/oncotarget.7313] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
63 de Oliveira PG, Ramos MLS, Amaro AJ, Dias RA, Vieira SI. Gi/o-Protein Coupled Receptors in the Aging Brain. Front Aging Neurosci 2019;11:89. [PMID: 31105551 DOI: 10.3389/fnagi.2019.00089] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
64 Dunn HA, Ferguson SSG. PDZ Protein Regulation of G Protein–Coupled Receptor Trafficking and Signaling Pathways. Mol Pharmacol 2015;88:624-39. [DOI: 10.1124/mol.115.098509] [Cited by in Crossref: 70] [Cited by in F6Publishing: 68] [Article Influence: 10.0] [Reference Citation Analysis]
65 Atanes P, Ashik T, Persaud SJ. Obesity-induced changes in human islet G protein-coupled receptor expression: Implications for metabolic regulation. Pharmacol Ther 2021;228:107928. [PMID: 34174278 DOI: 10.1016/j.pharmthera.2021.107928] [Reference Citation Analysis]
66 Rana S, Sahoo AR, Majhi BK. Structural complexes of the agonist, inverse agonist and antagonist bound C5a receptor: insights into pharmacology and signaling. Mol Biosyst 2016;12:1586-99. [PMID: 26978009 DOI: 10.1039/c6mb00031b] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
67 Huang Y, Todd N, Thathiah A. The role of GPCRs in neurodegenerative diseases: avenues for therapeutic intervention. Current Opinion in Pharmacology 2017;32:96-110. [DOI: 10.1016/j.coph.2017.02.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 7.2] [Reference Citation Analysis]
68 Mori Y, Tsuchihira A, Yoshida T, Yoshida S, Fujiuchi A, Ohmi M, Isogai Y, Sakaguchi T, Eguchi S, Tsuda T, Kato K, Ohashi K, Ouchi N, Park HM, Murohara T, Takefuji M. Corticotropin releasing hormone receptor 2 antagonist, RQ-00490721, for the prevention of pressure overload-induced cardiac dysfunction. Biomed Pharmacother 2021;146:112566. [PMID: 34954642 DOI: 10.1016/j.biopha.2021.112566] [Reference Citation Analysis]
69 Haque ME, Kim IS, Jakaria M, Akther M, Choi DK. Importance of GPCR-Mediated Microglial Activation in Alzheimer's Disease. Front Cell Neurosci 2018;12:258. [PMID: 30186116 DOI: 10.3389/fncel.2018.00258] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
70 Kononoff J, Kallupi M, Kimbrough A, Conlisk D, de Guglielmo G, George O. Systemic and Intra-Habenular Activation of the Orphan G Protein-Coupled Receptor GPR139 Decreases Compulsive-Like Alcohol Drinking and Hyperalgesia in Alcohol-Dependent Rats. eNeuro 2018;5:ENEURO. [PMID: 29971251 DOI: 10.1523/ENEURO.0153-18.2018] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
71 Stoy H, Gurevich VV. How genetic errors in GPCRs affect their function: Possible therapeutic strategies. Genes Dis 2015;2:108-32. [PMID: 26229975 DOI: 10.1016/j.gendis.2015.02.005] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 5.7] [Reference Citation Analysis]
72 Sengupta D, Kumar GA, Chattopadhyay A. Interaction of Membrane Cholesterol with GPCRs: Implications in Receptor Oligomerization. In: Herrick-davis K, Milligan G, Di Giovanni G, editors. G-Protein-Coupled Receptor Dimers. Cham: Springer International Publishing; 2017. pp. 415-29. [DOI: 10.1007/978-3-319-60174-8_16] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
73 Dalton JA, Lans I, Giraldo J. Quantifying conformational changes in GPCRs: glimpse of a common functional mechanism. BMC Bioinformatics 2015;16:124. [PMID: 25902715 DOI: 10.1186/s12859-015-0567-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
74 Jatana N, Aswin SK, Rathore S, Thukral L. Revealing Conformational Transitions in G-Protein-Coupled Receptor Rhodopsin upon Phosphorylation. Biochemistry 2020;59:297-302. [PMID: 31846310 DOI: 10.1021/acs.biochem.9b00884] [Reference Citation Analysis]
75 Hayn M, Blötz A, Rodríguez A, Vidal S, Preising N, Ständker L, Wiese S, Stürzel CM, Harms M, Gross R, Jung C, Kiene M, Jacob T, Pöhlmann S, Forssmann WG, Münch J, Sparrer KMJ, Seuwen K, Hahn BH, Kirchhoff F. Natural cystatin C fragments inhibit GPR15-mediated HIV and SIV infection without interfering with GPR15L signaling. Proc Natl Acad Sci U S A 2021;118:e2023776118. [PMID: 33431697 DOI: 10.1073/pnas.2023776118] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
76 Tsuda T, Takefuji M, Wettschureck N, Kotani K, Morimoto R, Okumura T, Kaur H, Eguchi S, Sakaguchi T, Ishihama S, Kikuchi R, Unno K, Matsushita K, Ishikawa S, Offermanns S, Murohara T. Corticotropin releasing hormone receptor 2 exacerbates chronic cardiac dysfunction. J Exp Med 2017;214:1877-88. [PMID: 28550160 DOI: 10.1084/jem.20161924] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
77 Ausländer S, Fussenegger M. Engineering Gene Circuits for Mammalian Cell-Based Applications. Cold Spring Harb Perspect Biol 2016;8:a023895. [PMID: 27194045 DOI: 10.1101/cshperspect.a023895] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
78 Zou R, Wang X, Li S, Chan HCS, Vogel H, Yuan S. The role of metal ions in G protein‐coupled receptor signalling and drug discovery. WIREs Comput Mol Sci 2022;12. [DOI: 10.1002/wcms.1565] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
79 Jafurulla M, Chattopadhyay A. Structural Stringency of Cholesterol for Membrane Protein Function Utilizing Stereoisomers as Novel Tools: A Review. In: Gelissen IC, Brown AJ, editors. Cholesterol Homeostasis. New York: Springer; 2017. pp. 21-39. [DOI: 10.1007/978-1-4939-6875-6_3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
80 Marciniak A, Camp SM, Garcia JGN, Polt R. In silico Docking Studies of Fingolimod and S1P1 Agonists. Front Pharmacol 2020;11:247. [PMID: 32210822 DOI: 10.3389/fphar.2020.00247] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
81 Hutter S, van Haaften WT, Hünerwadel A, Baebler K, Herfarth N, Raselli T, Mamie C, Misselwitz B, Rogler G, Weder B, Dijkstra G, Meier CF, de Vallière C, Weber A, Imenez Silva PH, Wagner CA, Frey-Wagner I, Ruiz PA, Hausmann M. Intestinal Activation of pH-Sensing Receptor OGR1 [GPR68] Contributes to Fibrogenesis. J Crohns Colitis 2018;12:1348-58. [PMID: 30165600 DOI: 10.1093/ecco-jcc/jjy118] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
82 Hu B, Gifford E, Wang H, Bailey W, Johnson T. Analysis of the ToxCast Chemical-Assay Space Using the Comparative Toxicogenomics Database. Chem Res Toxicol 2015;28:2210-23. [PMID: 26505644 DOI: 10.1021/acs.chemrestox.5b00369] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
83 Harini K, Jayashree S, Tiwari V, Vishwanath S, Sowdhamini R. Ligand Docking Methods to Recognize Allosteric Inhibitors for G-Protein-Coupled Receptors. Bioinform Biol Insights 2021;15:11779322211037769. [PMID: 34733103 DOI: 10.1177/11779322211037769] [Reference Citation Analysis]
84 Zhou DX, Zhao Y, Baker JA, Gu Q, Hamre KM, Yue J, Jones BC, Cook MN, Lu L. The effect of alcohol on the differential expression of cluster of differentiation 14 gene, associated pathways, and genetic network. PLoS One 2017;12:e0178689. [PMID: 28575045 DOI: 10.1371/journal.pone.0178689] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
85 Chakravorty D, Assmann SM. G protein subunit phosphorylation as a regulatory mechanism in heterotrimeric G protein signaling in mammals, yeast, and plants. Biochem J 2018;475:3331-57. [PMID: 30413679 DOI: 10.1042/BCJ20160819] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 6.3] [Reference Citation Analysis]
86 Fatima MT, Ahmed I, Fakhro KA, Akil ASA. Melanocortin-4 receptor complexity in energy homeostasis,obesity and drug development strategies. Diabetes Obes Metab 2022;24:583-98. [PMID: 34882941 DOI: 10.1111/dom.14618] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
87 Kumari N, Reabroi S, North BJ. Unraveling the Molecular Nexus between GPCRs, ERS, and EMT. Mediators Inflamm 2021;2021:6655417. [PMID: 33746610 DOI: 10.1155/2021/6655417] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
88 Pau A, Catto M, Pinna G, Frau S, Murineddu G, Asproni B, Curzu MM, Pisani L, Leonetti F, Loza MI, Brea J, Pinna GA, Carotti A. Multitarget-Directed Tricyclic Pyridazinones as G Protein-Coupled Receptor Ligands and Cholinesterase Inhibitors. ChemMedChem 2015;10:1054-70. [DOI: 10.1002/cmdc.201500124] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
89 Lolait SJ, Roper JA, Hazell GG, Li Y, Thomson FJ, O'carroll A. Neuropeptide Receptors. In: Murphy D, Gainer H, editors. Molecular Neuroendocrinology. Chichester: John Wiley & Sons, Ltd; 2016. pp. 195-215. [DOI: 10.1002/9781118760369.ch10] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
90 Schütz M, Schöppe J, Sedlák E, Hillenbrand M, Nagy-Davidescu G, Ehrenmann J, Klenk C, Egloff P, Kummer L, Plückthun A. Directed evolution of G protein-coupled receptors in yeast for higher functional production in eukaryotic expression hosts. Sci Rep 2016;6:21508. [PMID: 26911446 DOI: 10.1038/srep21508] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 6.5] [Reference Citation Analysis]
91 Ye H, Fussenegger M. Synthetic therapeutic gene circuits in mammalian cells. FEBS Lett 2014;588:2537-44. [PMID: 24844435 DOI: 10.1016/j.febslet.2014.05.003] [Cited by in Crossref: 50] [Cited by in F6Publishing: 39] [Article Influence: 6.3] [Reference Citation Analysis]
92 Liu C, Bonaventure P, Lee G, Nepomuceno D, Kuei C, Wu J, Li Q, Joseph V, Sutton SW, Eckert W, Yao X, Yieh L, Dvorak C, Carruthers N, Coate H, Yun S, Dugovic C, Harrington A, Lovenberg TW. GPR139, an Orphan Receptor Highly Enriched in the Habenula and Septum, Is Activated by the Essential Amino Acids L-Tryptophan and L-Phenylalanine. Mol Pharmacol 2015;88:911-25. [PMID: 26349500 DOI: 10.1124/mol.115.100412] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
93 Rehman A, Baloch NU, Morrow JP, Pacher P, Haskó G. Targeting of G-protein coupled receptors in sepsis. Pharmacol Ther 2020;211:107529. [PMID: 32197794 DOI: 10.1016/j.pharmthera.2020.107529] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
94 Xie M, Fussenegger M. Mammalian designer cells: Engineering principles and biomedical applications. Biotechnol J 2015;10:1005-18. [PMID: 26010998 DOI: 10.1002/biot.201400642] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
95 Wang Z, Zhang H, Wang J, Yang Y, Wu Q. RNA interference-mediated silencing of G protein-coupled receptor 137 inhibits human gastric cancer cell growth. Mol Med Rep 2015;11:2578-84. [PMID: 25514843 DOI: 10.3892/mmr.2014.3091] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
96 Chan HCS, McCarthy D, Li J, Palczewski K, Yuan S. Designing Safer Analgesics via μ-Opioid Receptor Pathways. Trends Pharmacol Sci 2017;38:1016-37. [PMID: 28935293 DOI: 10.1016/j.tips.2017.08.004] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 7.4] [Reference Citation Analysis]
97 Prasanna X, Jafurulla M, Sengupta D, Chattopadhyay A. The ganglioside GM1 interacts with the serotonin 1A receptor via the sphingolipid binding domain. Biochimica et Biophysica Acta (BBA) - Biomembranes 2016;1858:2818-26. [DOI: 10.1016/j.bbamem.2016.08.009] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 5.7] [Reference Citation Analysis]
98 Zhang C, Huang LS, Zhu R, Meng Q, Zhu S, Xu Y, Zhang H, Fang X, Zhang X, Zhou J, Schooley RT, Yang X, Huang Z, An J. High affinity CXCR4 inhibitors generated by linking low affinity peptides. Eur J Med Chem 2019;172:174-85. [PMID: 30978562 DOI: 10.1016/j.ejmech.2019.03.056] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
99 Tang W, Huang B, Wang J, An L, Zhong H, Yang H, Li P, Chen J. A label-free screening approach targeted protease-activated receptor 1 based on dynamic mass redistribution in living cells. RSC Adv 2017;7:43005-13. [DOI: 10.1039/c7ra07927c] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
100 Giuffrè M, Moretti R, Campisciano G, da Silveira ABM, Monda VM, Comar M, Di Bella S, Antonello RM, Luzzati R, Crocè LS. You Talking to Me? Says the Enteric Nervous System (ENS) to the Microbe. How Intestinal Microbes Interact with the ENS. J Clin Med 2020;9:E3705. [PMID: 33218203 DOI: 10.3390/jcm9113705] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
101 Prajapati R, Seong SH, Paudel P, Park SE, Jung HA, Choi JS. In Vitro and In Silico Characterization of Kurarinone as a Dopamine D1A Receptor Antagonist and D2L and D4 Receptor Agonist. ACS Omega 2021;6:33443-53. [PMID: 34926894 DOI: 10.1021/acsomega.1c04109] [Reference Citation Analysis]
102 Fu J, Lee T, Qi X. The identification of high-affinity G protein-coupled receptor ligands from large combinatorial libraries using multicolor quantum dot-labeled cell-based screening. Future Med Chem 2014;6:809-23. [PMID: 24941874 DOI: 10.4155/fmc.14.38] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
103 Sarparast M, Dattmore D, Alan J, Lee KSS. Cytochrome P450 Metabolism of Polyunsaturated Fatty Acids and Neurodegeneration. Nutrients 2020;12:E3523. [PMID: 33207662 DOI: 10.3390/nu12113523] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
104 Gaitonde SA, González-Maeso J. Contribution of heteromerization to G protein-coupled receptor function. Curr Opin Pharmacol 2017;32:23-31. [PMID: 27835800 DOI: 10.1016/j.coph.2016.10.006] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 6.3] [Reference Citation Analysis]
105 Lu J, Chen PP, Zhang JX, Li XQ, Wang GH, Yuan BY, Huang SJ, Liu XQ, Jiang TT, Wang MY, Liu WT, Ruan XZ, Liu BC, Ma KL. GPR43 deficiency protects against podocyte insulin resistance in diabetic nephropathy through the restoration of AMPKα activity. Theranostics 2021;11:4728-42. [PMID: 33754024 DOI: 10.7150/thno.56598] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
106 Hazem SH, Hamed MF, Saad MA, Gameil NM. Comparison of lactate and β-hydroxybutyrate in the treatment of concanavalin-A induced hepatitis. International Immunopharmacology 2018;61:376-84. [DOI: 10.1016/j.intimp.2018.06.026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
107 Huang S, Benben A, Green R, Cheranda N, Lee G, Joseph B, Keaveney S, Wang Y. Phosphorylation of the Gα protein Gpa2 promotes protein kinase A signaling in yeast. J Biol Chem 2019;294:18836-45. [PMID: 31690628 DOI: 10.1074/jbc.RA119.009609] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
108 Hofmann S, Maschauer S, Kuwert T, Beck-Sickinger AG, Prante O. Synthesis and in vitro and in vivo evaluation of an (18)F-labeled neuropeptide Y analogue for imaging of breast cancer by PET. Mol Pharm 2015;12:1121-30. [PMID: 25748228 DOI: 10.1021/mp500601z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
109 Masuho I, Balaji S, Muntean BS, Skamangas NK, Chavali S, Tesmer JJG, Babu MM, Martemyanov KA. A Global Map of G Protein Signaling Regulation by RGS Proteins. Cell 2020;183:503-521.e19. [PMID: 33007266 DOI: 10.1016/j.cell.2020.08.052] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]